Nonhormonal Treatment for Hot Flashes: Medicines, Therapy, and What to Ask

Nonhormonal treatment for hot flashes can include prescription medicines and behavioral approaches such as cognitive behavioral therapy. Fezolinetant is a nonhormonal medicine studied for moderate-to-severe menopausal vasomotor symptoms 1. The right option depends on symptom severity, health history, current medicines, and whether hot flashes may have another cause.

What are nonhormonal treatments for hot flashes?

Nonhormonal treatment for hot flashes includes certain prescription medicines, cognitive behavioral therapy (CBT), and practical changes that may reduce triggers. These options are most often used for bothersome menopausal vasomotor symptoms—hot flashes and night sweats—when systemic estrogen therapy is not desired or is not a good medical fit 3.

A clinician should match the approach to the symptom pattern and the person. For example, a medicine that may help nighttime symptoms can also cause daytime sleepiness, while another option may interact with an antidepressant or other medication already in use 3 7.

What are hot flashes and night sweats?

Hot flashes are sudden waves of heat, often with flushing, sweating, a faster heartbeat, or chills afterward. Night sweats occur during sleep and can leave a person waking repeatedly, changing clothes or bedding, or feeling exhausted the next day 3.

Together, hot flashes and night sweats are known as menopausal vasomotor symptoms, or VMS. Symptoms can start during perimenopause, the transition before menopause, and may continue after periods stop 3. For a broader overview of patterns and triggers, see our guide to menopause hot flashes.

Why do hot flashes happen during perimenopause and menopause?

The short answer is that fluctuating and declining estrogen appears to affect thermoregulation—how the brain controls body temperature. Estrogen withdrawal changes temperature signaling and may make sweating and shivering start within a narrower temperature range than before 3.

This is not simply a matter of being “too warm.” Brain chemicals including norepinephrine and serotonin are involved, which helps explain why some nonhormonal medicines that act on nervous-system signaling may reduce symptoms 3. Symptoms and timing vary widely, so a clinician should consider the full picture rather than assuming every episode of sweating is menopause.

Which nonhormonal medicines may help hot flashes?

Several medicine classes may help, but they have different evidence, risks, and regulatory status. Only some options are FDA-approved specifically for VMS; others may be prescribed off label, meaning the use differs from the medication’s FDA-approved indication 3 5.

Low-dose paroxetine is an SSRI with an FDA-approved indication for moderate-to-severe menopausal hot flashes 5. Other SSRIs and serotonin-norepinephrine reuptake inhibitors (SNRIs), including medicines in the same broad antidepressant categories, are used in clinical practice for VMS but are generally off label for that purpose 3. They can cause nausea, headache, dizziness, agitation, sleep changes, and sexual side effects, and they can interact with other medicines.

Gabapentin is another nonhormonal option sometimes used off label, particularly when nighttime symptoms and poor sleep are prominent. In a randomized trial involving women with breast cancer, gabapentin was associated with lower hot-flash scores, but dizziness and drowsiness were common concerns 7.

Oxybutynin is approved for bladder conditions, not hot flashes. A randomized trial found it reduced hot-flash frequency and severity compared with placebo, but anticholinergic effects such as dry mouth, constipation, blurred vision, and possible cognitive effects can limit its usefulness 8.

How does fezolinetant work for menopausal hot flashes?

Fezolinetant (Veozah) is an NK3 receptor antagonist, meaning it blocks neurokinin 3 signaling in a brain pathway involved in temperature regulation. It is nonhormonal: it does not add estrogen or progesterone 1 4.

In the phase 3 SKYLIGHT 1 randomized trial, fezolinetant reduced the frequency and severity of moderate-to-severe VMS more than placebo at weeks 4 and 12 1. A phase 3b randomized trial also found benefit in participants considered unsuitable for hormone therapy 2. These trial findings describe the studied medication and participants, not a guaranteed result for any individual.

Elinzanetant is another neurokinin-receptor medicine that has been studied for VMS, but medication availability and approved uses can change. A prescribing clinician can use current labeling and your health history to discuss which options are available and appropriate 9.

What should people know about fezolinetant safety and liver monitoring?

Fezolinetant is not right for everyone. Liver safety is a central part of prescribing, so the clinician should review current FDA-approved labeling, liver history, other medicines, and the required monitoring plan before and during treatment 4.

Clinical trials reported side effects including headache, abdominal pain, diarrhea, insomnia, and elevations in liver tests in some participants 1 2. A person who develops symptoms that could suggest liver trouble, such as yellowing of the skin or eyes, dark urine, or unusual fatigue, should seek prompt medical advice rather than waiting for a routine visit 4.

Can therapy or lifestyle changes help with hot flashes?

Yes—behavioral care can help many people manage the disruption caused by symptoms, although it may not remove every episode. CBT has human trial evidence for improving the impact and bother of menopausal symptoms, especially when sleep, stress, or worry about symptoms are part of the cycle 6.

Can cognitive behavioral therapy help people cope with hot flashes?

CBT teaches practical skills for noticing thoughts, stress responses, sleep habits, and behaviors that can make symptoms feel more disruptive. In the MENOS 2 randomized trial, group and self-help CBT improved hot-flash and night-sweat problem ratings compared with usual care 6.

CBT is not a claim that symptoms are “all in your head.” It is a structured approach to coping with a real physical symptom and can be used alongside clinician-directed medical care 6.

Which everyday changes may make hot flashes easier to manage?

A symptom diary can help identify personal patterns. Common triggers include alcohol, spicy foods, warm rooms, stress, and smoking, though triggers differ from person to person 3. Dressing in layers, keeping a bedroom cool, using breathable bedding, and having cool water available are low-risk ways to prepare for episodes.

Regular movement, sleep routines, and stress-management practices can support overall health during menopause, but they should not be presented as proven substitutes for prescription care when symptoms are severe. If hot flashes are affecting work, sleep, mood, or daily life, that is a good reason to discuss treatment choices with a clinician 3.

What about supplements, herbal remedies, and over-the-counter products?

The honest answer is that evidence for many supplements and herbal products is limited or inconsistent. “Natural” does not mean proven or risk-free, and product quality, dose, and drug interactions can vary 3.

Some products are marketed for black cohosh, soy, red clover, or other botanical ingredients, but results across studies have not been consistent enough to treat them as established replacements for prescription care 3 10. Discuss supplements with a clinician or pharmacist, particularly if you have liver disease, a history of hormone-sensitive cancer, or take prescription medicines. Our guide to hormone-free menopause supplements explains the evidence limits in more detail.

Could hot flashes be caused by something other than menopause?

Yes. New or atypical flushing and sweating should not automatically be blamed on menopause. Medication effects, thyroid disease, infection, anxiety, alcohol use, and other medical conditions can contribute to sweating or heat intolerance 3.

Seek clinical evaluation sooner if symptoms start suddenly, come with fever, unintentional weight change, chest pain, fainting, severe palpitations, or occur outside the expected life stage. A clinician can review your symptom timeline, medications, menstrual changes, and any needed testing.

When might hormone treatment be considered instead?

Systemic estrogen therapy is an FDA-approved treatment for moderate-to-severe menopausal hot flashes and night sweats, but it is not appropriate for every person. Hormone treatment requires an individualized risk-benefit discussion that considers age, symptom burden, medical history, whether a person has a uterus, and personal preferences 11.

For people with a uterus who use systemic estrogen, progesterone or a progestogen is generally used to protect the uterine lining 11. Risks can include blood clots, stroke, heart attack, and certain cancers depending on the individual and treatment type, so this is not a decision to make from a general article 11. You can read more in our guide to HRT for menopause.

What does nonhormonal hot-flash care at Chia include—and not include?

Chia does not list fezolinetant, paroxetine, elinzanetant, gabapentin, oxybutynin, or a nonhormonal prescription treatment specifically for hot flashes in our current public catalog. Our listed estradiol and progesterone treatments are hormonal, not nonhormonal hot-flash treatments.

How clinician-reviewed menopause care works at Chia

At Chia, you begin with a short online health questionnaire. A licensed U.S. provider reviews your information and may prescribe only when clinically appropriate; a prescription is never guaranteed. When a listed treatment is appropriate, medications are compounded in the U.S. by state-licensed 503A pharmacies, shipped to your door, and monitored through our patient portal.

When estradiol- or progesterone-containing treatment may be a separate conversation

For someone seeking a hormonal menopause-care discussion, Chia offers estradiol as cream, tablets, transdermal patch, or injection, with plans currently starting at $109 per month for tablets. We also offer the HRT for Women protocol, which includes oral estradiol and immediate-release progesterone and currently starts at $119 per month. These options require clinician review and do not replace nonhormonal medicines for a person who needs or prefers nonhormonal care.

When should someone seek medical care for hot flashes?

Talk with a clinician when hot flashes or night sweats disrupt sleep, work, mood, or relationships; when they are new or changing; or when you want help weighing treatment trade-offs. A clinical review is especially important when symptoms are unexplained or come with fever, chest pain, fainting, significant palpitations, or unintentional weight loss 3.

Bring a list of medicines and supplements, your menstrual history if relevant, and notes about when symptoms occur. That information can help distinguish likely menopause-related VMS from other possible causes and support a safer prescribing conversation.

Keep reading

Hormone Health

Menopause Hot Flashes: Causes, Triggers, and Treatment Options

Hormone Health

Perimenopause Treatment: What Helps Symptoms and When to Get Care

Menopause

Hot Flashes and Hormone Treatment: What Helps, What to Ask, and Who May Be Eligible